These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6812338)

  • 1. Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):486-91. PubMed ID: 6812338
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
    Hagen C; Christensen MS; Christiansen C; Stocklund KE; Transbøl I
    Acta Obstet Gynecol Scand; 1982; 61(3):237-41. PubMed ID: 6812385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.
    Andersen JR; Schroeder E; Lebech PE
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
    Staland B
    Maturitas; 1981 Aug; 3(2):145-56. PubMed ID: 7026979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral treatment of menopausal symptoms with natural oestrogens. Experiences with a new series of oestrogens and oestrogen-gestagen combinations.
    Borglin NE; Staland B
    Acta Obstet Gynecol Scand Suppl; 1975; 43():1-11. PubMed ID: 1060357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropins and prolactin during estrogen replacement therapy.
    Helgason S; Carlström K; Damber MG; von Schoultz B
    Acta Obstet Gynecol Scand; 1981; 60(5):515-6. PubMed ID: 6795895
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolactin levels in menopausal women on long-term estrogen implants.
    Goh HH; McCarthy TG; Dramusic V; Ratnam SS
    Gynecol Endocrinol; 1989 Jun; 3(2):153-7. PubMed ID: 2510462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of short-term estrogen replacement therapy (ERT) on the blood pressure and daily urinary catecholamine excretion in a small group of post-menopausal women.
    Blum M; Assa S; Bacalu B; Honig B; Blum I
    Eur J Obstet Gynecol Reprod Biol; 1986 Nov; 23(3-4):195-9. PubMed ID: 3817261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Climacteric symptoms, fat mass, and plasma concentrations of LH, FSH, Prl, oestradiol-17 beta and androstenedione in the early post-menopausal period.
    Hagen C; Christiansen C; Christensen MS; Transbøl I
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):87-92. PubMed ID: 6812347
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
    Aedo AR; Le Donne M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):147-57. PubMed ID: 2547138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
    Rutlin E; Haug E; Torjesen PA
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):23-35. PubMed ID: 401551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
    Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J
    Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Kliogest therapy on serum blood lipids in postmenopausal women].
    Warenik-Szymankiewicz A; Hadaś K; Halerz-Nowakowska B; Korcz-Maciejewska M; Meczekalski B; Dydowicz M; Wiza M
    Ginekol Pol; 1995 Sep; 66(9):541-6. PubMed ID: 8778013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.